Institutional Ownership
Xortx Therapeutics Inc
CUSIP 98420Q306COMXRTXQ1 2026
13D / 13G Filings
4
Schedule 13D/13G on record
Beneficial Filers
3
Distinct reporting persons
Largest Stake
10.0%
Max % of class reported
Institutional Holders
1
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
4 filings · latest Oct 27, 2025
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Td Waterhouse Canada Inc. | 47 | $19 |